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SYMMETRIC DIMETHYLARGININE (SDMA) AND
NEPHROPATHY IN DOG: DIAGNOSTIC UTILITY IN CLINI-
CAL PRACTICE. J. Zambarbieri, M. Giraldi, B. Ruggerone, S.
Faverzani, P. Scarpa. University of Milan, Milan, Italy
Symmetric dimethylarginine (SDMA) has been proposed as a sen-
sitive and specific renal biomarker whose concentration increases
earlier than serum creatinine (SCr) as glomerular filtration rate
decreases. SDMA is a promising parameter in the diagnosis and
management of chronic kidney disease (CKD) and it is included
into the International Renal Interest Society (IRIS) guidelines.
The aim of the study is to assess the usefulness of a single deter-
mination of SDMA in the evaluation of renal status in dogs at
risk or aﬀected with CKD, and to evaluate its correlation with
SCr and other parameters of renal function.
Ninety-five dogs were consecutively selected within the patients
referred to the University Veterinary Hospital of Milan. On the
first clinical examination, all these dogs underwent to physical
examination, hematology and blood chemistry (included serum
SDMA and SCr). Urinalysis and urinary protein:creatinine ratio
(UPC) were performed in 89 cases while ultrasound examination
was done in 60 dogs. All the dogs were staged according to the
IRIS guidelines. Statistical analysis was performed by JMP 7 soft-
ware (SAS Institute Inc., Cary, USA).
SDMA showed, as expected, a significant correlation with SCr,
urine specific gravity (USG) and UPC ratio (P < 0.05). IRIS stag-
ing, according to SCr, resulted as follows: 26 (27.4%) dogs were
included in stage 0, 39 (41%) in stage 1, 12 (12.6%) in stage 2, 17
(17.9%) in stage 3 and 1 (1.1%) in stage 4. SDMA evaluation
modified IRIS staging in 12 (12.6%) dogs. SDMA was increased
in 51 (53.7%) dogs; in 8 (15.7%) of these, SDMA was equal to
the cut-oﬀ value (14 lg/dL). In 29 (56.9%) of the “high SDMA”
cases, SCr was >1.4 mg/dL while in the others 22 (43.1%) there
were already one or more alterations: decrease of USG in 14
(63.6% of 22) cases, increase of UPC ratio in 15 (68.2%) cases,
ultrasound features suggestive of CKD in 9 (40.1%) cases. SDMA
was the only altered parameter in 4 (4.2%) dogs. SDMA was nor-
mal and creatinine slightly increased in 1 (1.1%) dog.
SDMA is a useful and reliable parameter for the diagnosis and
management of CKD but the evaluation of other markers of renal
function and diagnostic imaging are essential in order to correctly
approach the patient from the diagnostic and therapeutic point of
view, especially at the first clinical presentation. Furthermore,
patients with normal SCr and altered SDMA require a further
evaluations to confirm the development of CKD.
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ULTRASOUND-GUIDED RENAL BIOPSY SIGNIFICANTLY
INCREASES URINARY N-ACETYL-BETA-D-GLUCOSAMI-
NASE INDEX ACTIVITY IN DOGS WITH DIFFUSE
PARENCHYMAL NEPHROPATHIES. A.R. Codea1, V.M. Mir-
cean1, O. Sarpataki1, B. Sevastre1, A. Bizo2, C.P. Popovici1, S.A.
Bogdan1, L.I. Oana1. 1Faculty of Veterinary Medicine Cluj-
Napoca, Cluj-Napoca, Romania, 2University o Medicine and
Pharmacy ‘‘Iuliu Hatieganu’’, Cluj-Napoca, Romania
Ultrasound guided renal biopsy is an essential diagnostics method
which, by facilitating histopathological examination can increase
the accuracy of the diﬀerential diagnosis between acute and
chronic nephropathies and will help the clinician perform an etio-
logic diagnosis, issue a prognosis and orient the therapy of the
majority of parenchymal nephropathies. Due to the relative inva-
siveness and potential adverse eﬀects, the use of renal biopsy is
limited among practitioners. In this study we evaluate the intensity
of renal damage induced by renal cortex sampling and the clinical
consequences of such a procedure. We examined 28 dogs, mixed
breed and variable ages, 11 (39, 29 %) males and 17 (60, 71 %)
females that were referred to our clinic and underwent ultrasound
guided renal biopsy in order to establish a definite diagnosis.
Patients were presented with a variety of diﬀuse nephropathies:
kidney lymphoma: 1 (3.57%), glomerulonephritis: 13 (46.43%),
tubulointerstitial nephritis: 11 (39.29 %) and nephrocalcinosis: 3
(10.71%) of which 18 (64.29 %) were in acute kidney failure and
10 (35.71 %) were chronic renal patients. The type and the sever-
ity of renal lesions were correlated with changes in urinary NAG
index (iNAG), and specific serum renal damage markers such as
urea, creatinine, phosphorus and ionized calcium. To quantify the
side eﬀects of percutaneous renal biopsy the magnitude of post
biopsy hematuria and changes in urinary iNAG activity were eval-
uated. The results indicate a significant post biopsy increase in uri-
nary iNAG activity in all patients that underwent this procedure
(100.08 ! 34.45 (U/g) pre-biopsy iNAG vs. 147.65 ! 33.26 (U/g)
post-biopsy iNAG, P < 0.001) suggesting an intensification in
renal tubular damage consecutive to kidney puncture and
sampling.
Transitory macro- or microhematuria were constant findings in
all dogs that underwent ultrasound guided renal biopsy but the
magnitude and extent could not be associated with PLT(109/L),
aPTT (s) and PT (s) levels in our patients, and resolved after 12–
24 h without therapeutical interventions.
Percutaneous ultrasound guided renal biopsy is a relatively safe
minimal invasive diagnostic procedure which will induce a series
deleterious eﬀects on kidney structure and function, but we con-
sider that a correctly obtained tissue sample with a high diagnostic
value is of greater importance than the complications associated
the sampling procedure.
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EVALUATION OF INFECTIVE AND REPLICATIVE PROP-
ERTIES OF A REPLICATION-SELECTIVE ONCOLYTIC
VACCINIA VIRUS (VVTG17990) ON CANINE, FELINE, POR-
CINE AND HUMAN CELL LINES. J.S. B!eguin1, C. Maurey1,
V. Nourtier2, J. Foloppe2, P. Erbs2, B. Klonjkowski1. 1Ecole
Nationale V!et!erinaire d’Alfort, Universit!e Paris Est, Maisons-
Alfort, France, 2Transgene, Illkirch Graﬀenstaden, France
Oncolytic virotherapy with tumor selective viruses oﬀers a promis-
ing treatment modality for cancer. In human medicine, Vaccinia
virus (VV) has shown encouraging results on tumor explants. This
biotechnology is underused in veterinary oncology.
First objective of this study was to investigate the capacity of
various species cell lines to support infection by a replication-selec-
tive oncolytic VV (VVTG17990). Our second objective was to
assess replication potency of VVTG17990 on those cell lines.
A thymidine kinase and ribonucleotide reductase genes-deleted
VV expressing green fluorescent protein (GFP) was designed
(VVTG17990).
Non tumoral canine (DKE1), feline (CrFK), porcine (PK-15)
and human (293) cell lines were used as well as tumoral canine
(A72) and human (HeLa) cell lines.
Susceptibility was evaluated 16 h after infection with
VVTG17990 using fluorescence microscopy and flow cytometry.
Multiplicity of infection (MOI) of 0.1, 0.01 and 0.001 were tested.
Virus titers were evaluated 4 days after infection at a MOI of
0.0001 and 0.00001, by standard plaque forming assay on culture
medium and cell lysate.
All experiments were performed in triplicate.
GFP expression was detected by fluorescence microscopy 16 h
after infection for all cell lines even with low infective doses. Flow
cytometry allowed an assessment of a dose dependent infection of
cells. For all cell lines, more than 88% of cells were infected at a
MOI of 0.1. Equivalent percentage of infection was noticed for
HeLa, 293 and PK-15 at a MOI of 0.01. On the other hand, lower
infection was assessed for DKE1 (55%), A72 (27%) and CrFK
(21%). At a MOI of 0.001, higher percentage of infection was
observed for 293 (32%) and PK-15 (25%). For the others, less
than 13% of cells were infected. Tumoral status of cell lines didn’t
seem to influence susceptibility to VVTG17990.
Interestingly, 16 h after infection VVTG17990 proved eﬀective
lytic potency on cell lines. Lytic potency was more important with
higher viral doses.
A replication factor of 106 to 107 was determined 4 days after
infection for all cell lines, except for feline cell lines (about 103).
Tumoral status of cell lines didn’t seem to influence the replication
factor.
This study proves that canine, porcine and human cell lines sup-
port infection by VVTG17990 with a high replication factor. In
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